Clinical trial · Observational
Survey Study: Financial Impact of Breast Cancer Treatment
Determining the Financial Impact of Breast Cancer Treatment Over a One Year Period for Patients at a Rural Cancer Center
NCT03615573CI-TRIAL-00082346completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A survey study to evaluate the financial impact of breast cancer as self-reported by breast cancer patients over a period of 1 year. The study will also look at the health insurance literacy and patient's utilization of support services.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Quality of Life Surveys | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Change in level of self-reported financial burden
- timeFrame
- Baseline through 1 year
- description
- Will evaluate the change in Comprehensive Score for Financial Toxicity (COST-FACIT) measurements from baseline to 1 year follow up. This survey consists of 14 questions related to finances.Responses include 5 options with lower scores representing worse outcomes. Scores at 1 year will be compared to baseline scores.
Secondary outcomes (2)
- measure
- Change in level of self-reported health insurance literacy
- timeFrame
- Baseline through 1 year
- description
- Will evaluate the change in Health Insurance Literacy Measurements (HILM) from baseline to 1 year follow up
- measure
- Self-reported access and utilization of institutional support services
- timeFrame
- Baseline through 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years or older * Diagnosed with breast cancer or a recurrence of breast cancer within the past 2 years * Willing to sign consent * Able to read and complete surveys in English Exclusion Criteria: * Cancer diagnosis other than breast cancer * More than 2 years since diagnosis with breast cancer or recurrence
References
Publications (0)
Data not yet available
No reference posted for this study.